Green and Cost-Effective Synthesis of Metallic Nanoparticles by Algae: Safe Methods for Translational Medicine.

algal nanotechnology metallic nanoparticles nanomedicine nanoparticle biosynthesis sustainable technology translational medicine

Journal

Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056

Informations de publication

Date de publication:
16 Oct 2020
Historique:
received: 07 09 2020
revised: 16 09 2020
accepted: 17 09 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

Metal nanoparticles (NPs) have received much attention for potential applications in medicine (mainly in oncology, radiology and infectiology), due to their intriguing chemical, electronical, catalytical, and optical properties such as surface plasmon resonance (SPR) effect. They also offer ease in controlled synthesis and surface modification (e.g., tailored properties conferred by capping/protecting agents including N-, P-, COOH-, SH-containing molecules and polymers such as thiol, disulfide, ammonium, amine, and multidentate carboxylate), which allows (i) tuning their size and shape (e.g., star-shaped and/or branched) (ii) improving their stability, monodispersity, chemical miscibility, and activity, (iii) avoiding their aggregation and oxidation over time, (iv) increasing their yield and purity. The bottom-up approach, where the metal ions are reduced in the NPs grown in the presence of capping ligands, has been widely used compared to the top-down approach. Besides the physical and chemical synthesis methods, the biological method is gaining much consideration. Indeed, several drawbacks have been reported for the synthesis of NPs via physical (e.g., irradiation, ultrasonication) and chemical (e.g., electrochemisty, reduction by chemicals such as trisodium citrate or ascorbic acid) methods (e.g., cost, and/ortoxicity due to use of hazardous solvents, low production rate, use of huge amount of energy). However, (organic or inorganic) eco-friendly NPs synthesis exhibits a sustainable, safe, and economical solution. Thereby, a relatively new trend for fast and valuable NPs synthesis from (live or dead) algae (i.e., microalgae, macroalgae and cyanobacteria) has been observed, especially because of its massive presence on the Earth's crust and their unique properties (e.g., capacity to accumulate and reduce metallic ions, fast propagation). This article discusses the algal-mediated synthesis methods (either intracellularly or extracellularly) of inorganic NPs with special emphasis on the noblest metals, i.e., silver (Ag)- and gold (Au)-derived NPs. The key factors (e.g., pH, temperature, reaction time) that affect their biosynthesis process, stability, size, and shape are highlighted. Eventually, underlying molecular mechanisms, nanotoxicity and examples of major biomedical applications of these algal-derived NPs are presented.

Identifiants

pubmed: 33081248
pii: bioengineering7040129
doi: 10.3390/bioengineering7040129
pmc: PMC7712047
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Nanomaterials (Basel). 2016 Dec 06;6(12):
pubmed: 28335363
Appl Biochem Biotechnol. 2015 Aug;176(7):1937-49
pubmed: 26041058
Nanomaterials (Basel). 2018 May 18;8(5):
pubmed: 29783714
Microbiology (Reading). 2013 Mar;159(Pt 3):641-648
pubmed: 23329680
Materials (Basel). 2015 Oct 29;8(11):7278-7308
pubmed: 28793638
Acta Biomater. 2008 May;4(3):707-16
pubmed: 18248860
Colloids Surf B Biointerfaces. 2007 May 15;57(1):97-101
pubmed: 17350236
Biotechnol Adv. 2009 Jan-Feb;27(1):76-83
pubmed: 18854209
J Food Sci. 2009 Jan-Feb;74(1):M46-52
pubmed: 19200107
Toxicol Lett. 2013 Mar 13;217(3):205-16
pubmed: 23246733
Artif Cells Nanomed Biotechnol. 2018;46(sup1):1210-1220
pubmed: 29533101
J Appl Phycol. 2016;28:1051-1061
pubmed: 27057088
J Microbiol Methods. 2019 Aug;163:105656
pubmed: 31220512
Biomaterials. 2005 Jun;26(18):3995-4021
pubmed: 15626447
Colloids Surf B Biointerfaces. 2017 May 1;153:190-198
pubmed: 28242372
J Nanosci Nanotechnol. 2007 Aug;7(8):2696-708
pubmed: 17685286
IET Nanobiotechnol. 2013 Sep;7(3):109-16
pubmed: 24028809
Adv Pharm Bull. 2015 Nov;5(4):447-54
pubmed: 26819915
Int J Biol Macromol. 2020 Feb 1;144:921-931
pubmed: 31704336
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1803-15
pubmed: 23892192
Adv Drug Deliv Rev. 2011 Jan-Feb;63(1-2):24-46
pubmed: 20685224
Microb Cell Fact. 2018 Mar 5;17(1):36
pubmed: 29506528
Nanomedicine (Lond). 2007 Oct;2(5):681-93
pubmed: 17976030
Mar Drugs. 2017 Jan 18;15(1):
pubmed: 28106757
Bioprocess Biosyst Eng. 2014 Aug;37(8):1591-7
pubmed: 24525832
Bioresour Technol. 2003 Jul;88(3):179-84
pubmed: 12618038
Bioinorg Chem Appl. 2018 Oct 21;2018:7879403
pubmed: 30420873
Biotechnol Appl Biochem. 2010 Oct;57(2):71-5
pubmed: 20923412
Molecules. 2013 May 21;18(5):5954-64
pubmed: 23698048
Evid Based Complement Alternat Med. 2016;2016:7803846
pubmed: 27293463
Bioresour Technol. 2017 Nov;244(Pt 2):1407-1415
pubmed: 28697977
Theranostics. 2019 Oct 16;9(25):7906-7923
pubmed: 31695807
Int J Mol Sci. 2018 Oct 29;19(11):
pubmed: 30380664
Virulence. 2011 Sep-Oct;2(5):395-401
pubmed: 21921677
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1307-1315
pubmed: 18555555
J Photochem Photobiol B. 2014 Sep 5;138:302-6
pubmed: 25022464
J Microbiol Biotechnol. 2014 Oct;24(10):1354-67
pubmed: 24986675
Biotechnol Prog. 2006 Mar-Apr;22(2):577-83
pubmed: 16599579
Biotechnol Bioeng. 2012 Jan;109(1):284-8
pubmed: 21809325
Evid Based Complement Alternat Med. 2015;2015:246012
pubmed: 25861355
Biomed Res Int. 2014;2014:753419
pubmed: 25028666
Biopolymers. 2009 Nov;91(11):895-906
pubmed: 19585561
J Sci Food Agric. 2017 Feb;97(3):724-732
pubmed: 27507218
Materials (Basel). 2013 Dec 18;6(12):5942-5950
pubmed: 28788431
Expert Opin Drug Deliv. 2010 Jun;7(6):753-63
pubmed: 20408736
J Colloid Interface Sci. 2011 Nov 15;363(2):481-9
pubmed: 21855892
Nanoscale Res Lett. 2011 Dec;6(1):32
pubmed: 27502655
Langmuir. 2006 Jan 17;22(2):736-41
pubmed: 16401125
Appl Biochem Biotechnol. 2014 Dec;174(8):2777-90
pubmed: 25380639
Environ Monit Assess. 2017 Jul;189(7):349
pubmed: 28646435
Methods Mol Biol. 2012;906:3-19
pubmed: 22791420
Nanomedicine. 2010 Apr;6(2):257-62
pubmed: 19616126

Auteurs

Bushra Uzair (B)

Department of Bioinformatics and Biotechnology, Islamic International University, Islamabad 44000, Pakistan.

Ayesha Liaqat (A)

Department of Bioinformatics and Biotechnology, Islamic International University, Islamabad 44000, Pakistan.

Haroon Iqbal (H)

College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

Bouzid Menaa (B)

Department of Oncology and Nanomedicine, California Innovations Corp., San Diego, La Jolla, CA 92037, USA.

Anam Razzaq (A)

College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

Gobika Thiripuranathar (G)

Institute of Chemistry Ceylon, College of Chemical Sciences, Welikada, Rajagiriya 10107, Sri Lanka.

Nosheen Fatima Rana (N)

Department of Biomedical Engineering & Sciences, School of Mechanical & Manufacturing Engineering, National University of Sciences & Technology, Islamabad 44000, Pakistan.

Farid Menaa (F)

Department of Oncology and Nanomedicine, California Innovations Corp., San Diego, La Jolla, CA 92037, USA.

Classifications MeSH